Analyst Price Targets — JAN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 15, 2026 10:01 am | John Kilichowski | Wells Fargo | $33.00 | $29.56 | TheFly | Janus Living price target raised to $33 from $31 at Wells Fargo |
| July 7, 2026 11:52 am | — | Barclays | $33.00 | $29.38 | TheFly | Janus Living price target raised to $33 from $30 at Barclays |
| June 18, 2026 12:35 pm | — | UBS | $29.00 | $25.38 | TheFly | Janus Living price target lowered to $29 from $30 at Scotiabank |
| June 16, 2026 8:11 pm | — | Raymond James | $34.00 | $25.37 | TheFly | Janus Living initiated with a Strong Buy at Raymond James |
| June 10, 2026 10:16 am | — | KeyBanc | $29.00 | $25.42 | TheFly | Janus Living price target raised to $29 from $28 at KeyBanc |
| May 27, 2026 2:51 pm | — | Scotiabank | $30.00 | $27.12 | TheFly | Janus Living price target raised to $30 from $28 at Scotiabank |
| May 13, 2026 9:08 am | Richard Hightower | Barclays | $30.00 | $27.02 | TheFly | Janus Living price target raised to $30 from $26 at Barclays |
| May 8, 2026 3:43 pm | Michael Carroll | RBC Capital | $30.00 | $27.99 | TheFly | Janus Living price target raised to $30 from $27 at RBC Capital |
| April 14, 2026 12:44 pm | — | Scotiabank | $28.00 | $24.65 | TheFly | Janus Living initiated with an Outperform at Scotiabank |
| April 14, 2026 11:00 am | Julien Blouin | Goldman Sachs | $27.00 | $23.99 | TheFly | Janus Living initiated with a Neutral at Goldman Sachs |
Latest News for JAN
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced that on July 8, 2026, its Board of Directors declared a monthly common stock cash dividend of $0.0475 per share for the third quarter of 2026, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the…
Janus Living stands as the only pure-play senior housing REIT, offering direct SHOP exposure and unique sector positioning. JAN trades at a lower AFFO multiple than peers, yet its negative net debt and cash hoard suggest a leverage-neutral undervaluation. With $1.67B in cash, JAN is poised for $2.4B+ in accretive acquisitions, targeting 7.5% unlevered returns and rapid AFFO/share growth.
Janus Living, recently spun off from Healthpeak Properties, presents a new REIT opportunity in the senior-living sector. JAN benefits from Healthpeak's external management and affiliation, potentially enhancing its competitive positioning among senior care REIT peers. Key investment considerations include top-line growth drivers, margin trends, balance sheet strength, and dividend dynamics relative to sector peers.
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN), a pure-play senior housing real estate investment trust (REIT), is scheduled to report second quarter 2026 financial results after the close of trading on the New York Stock Exchange on Tuesday, August 4, 2026.Janus Living will host a conference call and webcast on Wednesday, August 5, 2026 at 12:00 p.m. Eastern Time to review its financial performance and…
DENVER--(BUSINESS WIRE)--Janus Living, Inc. (NYSE: JAN) (“Janus Living”), a pure-play senior housing real estate investment trust (REIT), announced today the pricing of its public offering of 25,000,000 shares of its Class A-1 common stock at a price to the public of $25.00 per share. In addition, Janus Living has granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of its Class…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for JAN.
U.S. House Trading
No House trades found for JAN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.